LINC01023

Across TCGA pan-cancer cohorts, LINC01023 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC01023’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01023 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01023 is over-expressed in tumor, although a few such as LUAD and THCA show the opposite, repressed pattern.

LUAD, THCA, and COAD are the cancer types where LINC01023 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01023 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	II,III,IV	−0.866	<.001	10	view →
THCA	Male	All	−0.798	<.001	9	view →
COAD	Male	II,III,IV	−0.583	<.001	7	view →
BRCA	Female	II,III,IV	−0.724	<.001	6	view →
KICH	All	All	−0.970	<.001	4	view →
CHOL	All	All	+0.956	<.001	3	view →
LIHC	All	All	+0.443	.003	3	view →
STAD	All	All	−0.423	.012	3	view →
LUSC	Male	III,IV	−1.364	.005	2	view →
UCEC	All	II,III,IV	−0.848	.044	2	view →
KIRP	All	All	−0.727	<.001	2	view →
KIRC	All	All	−0.364	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

LINC01023–LUAD

Open the LUAD breakdown →